YANNI, JOHN M.,CHATTERTON, JON E.,GAMACHE, DANIEL A.,MILLER, STEVEN T.
申请号：
CA2649138
公开号：
CA2649138C
申请日:
2007.04.13
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
RNA interference is provided for inhibition of spleen tyrosine kinase (Syk) mRNA expression, in particular, for treating patients having a Syk-related inflammatory condition or at risk of developing a Syk-related inflammatory condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, allergy, or mast-cell disease.
